勃起不全デバイスの世界市場：洞察、競合情勢、市場予測：2030年

世界の勃起不全デバイスの市場規模は、2023年に17億7,000万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に9.46%のCAGRで拡大すると予測されています。同市場は、勃起不全の症例の増加、男性の老年人口の増加、喫煙や飲酒を伴う座りがちなライフスタイル、肥満、勃起不全デバイス製品開発における技術進歩などにより、大きな成長が見込まれています。

勃起不全デバイス市場は、男性の勃起不全（ED）患者の有病率の上昇により大幅に増加しています。そのため、男性の高齢者人口の増加は、勃起不全デバイス市場の成長を後押しする重要な要因です。

最近の研究では、高血圧のような心臓病と勃起不全の間に関連性があることが示唆されています。陰茎は勃起のために十分な血流を必要とし、心臓が正常に働かなければ、人は勃起不全の影響を受けます。同様に、糖尿病のリスク増加にもつながります。米国疾病予防管理センター（Centers for Disease Control and Prevention 2022）によると、糖尿病の男性はEDになる可能性が3倍高いことがわかっています。

米国疾病管理予防センター（Centers for Disease Control and Prevention 2022）が提供する喫煙統計によると、喫煙も男性の勃起不全の原因として知られる要因の一つです。

このように、急増する心血管疾患の症例と喫煙、アルコール摂取に関連する日々の生活様式は、世界の勃起不全デバイス市場の成長に寄与します。

当レポートでは、世界の勃起不全デバイス市場について調査し、市場の概要とともに、製品別、アプローチ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 勃起不全デバイス市場レポートのイントロダクション

第2章 勃起不全デバイス市場のエグゼクティブサマリー

第3章 規制と特許の分析

• 米国
• 欧州
• 日本

第4章 勃起不全デバイス市場の主な要因分析

• 勃起不全デバイス市場の促進要因
• 勃起不全デバイス市場の抑制要因と課題
• 勃起不全デバイス市場の機会

第5章 勃起不全デバイスにおけるポーターのファイブフォース分析

第6章 勃起不全デバイス市場に対するCOVID-19の影響分析

第7章 勃起不全デバイス市場の概要

• 製品別
• アプローチ別
• エンドユーザー別
• 地域別

第8章 勃起不全デバイスの世界企業シェア分析-主要3～5社

第9章 勃起不全デバイスの企業と製品プロファイル

• Coloplast Corporation
• Zimmer Aesthetics
• Augusta Medical Systems
• Medispec Ltd.
• MTS Medical UG
• NOVAmedtek
• Shenzhen Huikang Medical Apparatus Co., Ltd.
• Promedon
• Boston Scientific Corporation
• Global Life Technologies LLC
• Zephyr Surgical Implants
• UroMatrix Medical Systems
• Pos-T-Vac Medical
• Owen Mumford Ltd.
• Vacurect Manufacturing (PTY) Ltd.
• The Elator
• SILIMED
• Tyna International Ltd.
• STORZ MEDICAL AG
• Reflexonic, LLC

第10章 プロジェクトのアプローチ

第11章 KOLの見解

第12章 DelveInsightのサービス内容

第13章 免責事項

第14章 DelveInsightについて

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis on Erectile Dysfunction Devices Market
• Table 3: Erectile Dysfunction Devices Market Analysis in Global (2021-2030)
• Table 4: Erectile Dysfunction Devices Market Analysis in Global by Product (2021-2030)
• Table 5: Erectile Dysfunction Devices Market Analysis in Global by Approach (2021-2030)
• Table 6: Erectile Dysfunction Devices Market Analysis in Global by End User (2021-2030)
• Table 7: Erectile Dysfunction Devices Market Analysis in Global by Geography (2021-2030)
• Table 8: Erectile Dysfunction Devices Market Analysis in North America (2021-2030)
• Table 9: Erectile Dysfunction Devices Market Analysis in North America by Product (2021-2030)
• Table 10: Erectile Dysfunction Devices Market Analysis in North America by Approach (2021-2030)
• Table 11: Erectile Dysfunction Devices Market Analysis in North America by End User (2021-2030)
• Table 12: Erectile Dysfunction Devices Market Analysis in North America by Country (2021-2030)
• Table 13: Erectile Dysfunction Devices Market Analysis in the US (2021-2030)
• Table 14: Erectile Dysfunction Devices Market Analysis in Canada (2021-2030)
• Table 15: Erectile Dysfunction Devices Market Analysis in Mexico (2021-2030)
• Table 16: Erectile Dysfunction Devices Market Analysis in Europe (2021-2030)
• Table 17: Erectile Dysfunction Devices Market Analysis in Europe by Product (2021-2030)
• Table 18: Erectile Dysfunction Devices Market Analysis in Europe by Approach (2021-2030)
• Table 19: Erectile Dysfunction Devices Market Analysis in Europe by End User (2021-2030)
• Table 20: Erectile Dysfunction Devices Market Analysis in Europe by Country (2021-2030)
• Table 21: Erectile Dysfunction Devices Market Analysis in France (2021-2030)
• Table 22: Erectile Dysfunction Devices Market Analysis in Germany (2021-2030)
• Table 23: Erectile Dysfunction Devices Market Analysis in UK (2021-2030)
• Table 24: Erectile Dysfunction Devices Market Analysis in Italy (2021-2030)
• Table 25: Erectile Dysfunction Devices Market Analysis in Spain (2021-2030)
• Table 26: Erectile Dysfunction Devices Market Analysis in Russia (2021-2030)
• Table 27: Erectile Dysfunction Devices Market Analysis in Rest of Europe (2021-2030)
• Table 28: Erectile Dysfunction Devices Market Analysis in Asia Pacific (2021-2030)
• Table 29: Erectile Dysfunction Devices Market Analysis in Asia Pacific by Product (2021-2030)
• Table 30: Erectile Dysfunction Devices Market Analysis in Asia Pacific by Approach (2021-2030)
• Table 31: Erectile Dysfunction Devices Market Analysis in Asia Pacific by End User (2021-2030)
• Table 32: Erectile Dysfunction Devices Market Analysis in Asia Pacific by Country (2021-2030)
• Table 33: Erectile Dysfunction Devices Market Analysis in China (2021-2030)
• Table 34: Erectile Dysfunction Devices Market Analysis in Japan (2021-2030)
• Table 35: Erectile Dysfunction Devices Market Analysis in India (2021-2030)
• Table 36: Erectile Dysfunction Devices Market Analysis in Australia (2021-2030)
• Table 37: Erectile Dysfunction Devices Market Analysis in South Korea (2021-2030)
• Table 38: Erectile Dysfunction Devices Market Analysis in Rest of Asia Pacific (2021-2030)
• Table 39: Erectile Dysfunction Devices Market Analysis in Rest of the World (2021-2030)
• Table 40: Erectile Dysfunction Devices Market Analysis in Rest of the World by Product (2021-2030)
• Table 41: Erectile Dysfunction Devices Market Analysis in Rest of the World by Approach (2021-2030)
• Table 42: Erectile Dysfunction Devices Market Analysis in Rest of the World by End User (2021-2030)
• Table 43: Erectile Dysfunction Devices Market Analysis in Rest of the World by Country (2021-2030)
• Table 44: Erectile Dysfunction Devices Market Analysis in Middle East (2021-2030)
• Table 45: Erectile Dysfunction Devices Market Analysis in Africa (2021-2030)
• Table 46: Erectile Dysfunction Devices Market Analysis in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis on Erectile Dysfunction Devices Market
• Figure 3: Erectile Dysfunction Devices Market Analysis in Global (2021-2030)
• Figure 4: Erectile Dysfunction Devices Market Analysis in Global by Product (2021-2030)
• Figure 5: Erectile Dysfunction Devices Market Analysis in Global by Approach (2021-2030)
• Figure 6: Erectile Dysfunction Devices Market Analysis in Global by End User (2021-2030)
• Figure 7: Erectile Dysfunction Devices Market Analysis in Global by Geography (2021-2030)
• Figure 8: Erectile Dysfunction Devices Market Analysis in North America (2021-2030)
• Figure 9: Erectile Dysfunction Devices Market Analysis in North America by Product (2021-2030)
• Figure 10: Erectile Dysfunction Devices Market Analysis in North America by Approach (2021-2030)
• Figure 11: Erectile Dysfunction Devices Market Analysis in North America by End User (2021-2030)
• Figure 12: Erectile Dysfunction Devices Market Analysis in North America by Country (2021-2030)
• Figure 13: Erectile Dysfunction Devices Market Analysis in the US (2021-2030)
• Figure 14: Erectile Dysfunction Devices Market Analysis in Canada (2021-2030)
• Figure 15: Erectile Dysfunction Devices Market Analysis in Mexico (2021-2030)
• Figure 16: Erectile Dysfunction Devices Market Analysis in Europe (2021-2030)
• Figure 17: Erectile Dysfunction Devices Market Analysis in Europe by Product (2021-2030)
• Figure 18: Erectile Dysfunction Devices Market Analysis in Europe by Approach (2021-2030)
• Figure 19: Erectile Dysfunction Devices Market Analysis in Europe by End User (2021-2030)
• Figure 20: Erectile Dysfunction Devices Market Analysis in Europe by Country (2021-2030)
• Figure 21: Erectile Dysfunction Devices Market Analysis in France (2021-2030)
• Figure 22: Erectile Dysfunction Devices Market Analysis in Germany (2021-2030)
• Figure 23: Erectile Dysfunction Devices Market Analysis in UK (2021-2030)
• Figure 24: Erectile Dysfunction Devices Market Analysis in Italy (2021-2030)
• Figure 25: Erectile Dysfunction Devices Market Analysis in Spain (2021-2030)
• Figure 26: Erectile Dysfunction Devices Market Analysis in Russia (2021-2030)
• Figure 27: Erectile Dysfunction Devices Market Analysis in Rest of Europe (2021-2030)
• Figure 28: Erectile Dysfunction Devices Market Analysis in Asia Pacific (2021-2030)
• Figure 29: Erectile Dysfunction Devices Market Analysis in Asia Pacific by Product (2021-2030)
• Figure 30: Erectile Dysfunction Devices Market Analysis in Asia Pacific by Approach (2021-2030)
• Figure 31: Erectile Dysfunction Devices Market Analysis in Asia Pacific by End User (2021-2030)
• Figure 32: Erectile Dysfunction Devices Market Analysis in Asia Pacific by Country (2021-2030)
• Figure 33: Erectile Dysfunction Devices Market Analysis in China (2021-2030)
• Figure 34: Erectile Dysfunction Devices Market Analysis in Japan (2021-2030)
• Figure 35: Erectile Dysfunction Devices Market Analysis in India (2021-2030)
• Figure 36: Erectile Dysfunction Devices Market Analysis in Australia (2021-2030)
• Figure 37: Erectile Dysfunction Devices Market Analysis in South Korea (2021-2030)
• Figure 38: Erectile Dysfunction Devices Market Analysis in Rest of Asia Pacific (2021-2030)
• Figure 39: Erectile Dysfunction Devices Market Analysis in Rest of the World (2021-2030)
• Figure 40: Erectile Dysfunction Devices Market Analysis in Rest of the World by Product (2021-2030)
• Figure 41: Erectile Dysfunction Devices Market Analysis in Rest of the World by Approach (2021-2030)
• Figure 42: Erectile Dysfunction Devices Market Analysis in Rest of the World by End User (2021-2030)
• Figure 43: Erectile Dysfunction Devices Market Analysis in Rest of the World by Country (2021-2030)
• Figure 44: Erectile Dysfunction Devices Market Analysis in Middle East (2021-2030)
• Figure 45: Erectile Dysfunction Devices Market Analysis in Africa (2021-2030)
• Figure 46: Erectile Dysfunction Devices Market Analysis in South America (2021-2030)
• Figure 47: Market Drivers
• Figure 48: Market Barriers
• Figure 49: Market Opportunities
• Figure 50: PORTER'S Five Force Analysis

Erectile Dysfunction Devices Market By Product (Penile Implants, Shockwave Therapy Devices, Vacuum Therapy Devices, Others), By Approach (Invasive, Non-Invasive), By End-User (Hospitals and Clinics, Ambulatory Surgical Centers (Asc), Others), By Geography is expected to grow at a steady CAGR forecast till 2030 owing to growing cases of erectile dysfunction and increase in geriatric population of men.

Global Erectile Dysfunction Devices Market was valued at USD 1.77 billion in 2023, growing at a CAGR of 9.46% during the forecast period from 2024 to 2030, to reach USD 1.77 billion by 2030. The Erectile Dysfunction Devices market is expected to witness significant growth owing to the growing cases of erectile dysfunction, increase in the geriatric population of men, sedentary lifestyle that involves smoking, alcohol consumption, obesity, and technological advancements among Erectile Dysfunction Devices product development.

Erectile Dysfunction Devices Market Dynamics:

Erectile Dysfunction Devices Market has significantly increased owing to the rising prevalence of erectile dysfunction (ED) cases among men. Moreover, as per the CDC 2022, getting aged doesn't cause ED, but it does increase the chances of being affected by it. Thereby, an increase in the geriatric population of men is a significant factor that boosts the growth of the Erectile Dysfunction Devices Market.

Some recent studies have suggested that there is a link between heart diseases like hypertension and erectile dysfunction. Penis requires adequate blood flow for erection, if the heart is not working properly, a person will be affected with erectile dysfunction. Similarly, it is also linked with an increased risk of diabetes. As per the Centers for Disease Control and Prevention 2022, men with diabetes are three times more likely to have ED.

According to the Smoking statistics provided by the Centers for Disease Control and Prevention 2022, smoking is also one of the factors known for the cause of erectile dysfunction in males.

Thus, the burgeoning cases of cardiovascular disease and day-to-day lifestyle patterns associated with smoking, alcohol consumption will contribute to the Global Erectile Dysfunction Devices Market growth.

In addition, the integration of advanced technologies into Erectile Dysfunction Devices is advancing at a great pace. For instance, in January 2020, Morari Medical developed a wearable device that treated premature ejaculation using neuromodulation. Such technological advancement in the field of Erectile Dysfunction Devices is likely to boost the Global Erectile Dysfunction Devices Market.

The outbreak of the pandemic led to the cancellation of outpatient visits and the suspension of non-emergency hospitals and procedures. This resulted in the reduced number of routine clinical examinations of the gynecological visits and related procedures. However, vaccine development of COVID-19 has initiated the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape which has initiated the process of resumption of regular healthcare services such as outpatients visits and resumption of healthcare services, thereby bringing the demand for products on track in the Erectile Dysfunction Devices market.

However, certain factors like the availability of alternative drugs, and the high cost of invasive devices may restrict the growth of the Global Erectile Dysfunction Devices Market.

Erectile Dysfunction Devices Market Segment Analysis:

Erectile Dysfunction Devices Market By Product (Penile Implants, Shockwave Therapy Devices, Vacuum Therapy Devices, Others), By Approach (Invasive, Non-Invasive), By End-User (Hospitals and Clinics, Ambulatory Surgical Centers (ASC), Others) and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product segment of the Erectile Dysfunction Devices market, the Vacuum Therapy Devices market segment will hold the major share of the Global Erectile Dysfunction Devices market. The large market share of this product segment can be attributed to the growing adoption of these devices, their simplicity, and the overall good satisfaction of patients. These devices are cost-effective and FDA-approved.

Moreover, Vacuum Therapy Devices do not require any medication or surgery to be implanted and are least invasive thus, gaining commercial acceptability, which improves market penetration.

Thus, all the above-mentioned factors are significantly boosting the market growth. Thus, the Vacuum Therapy Devices segment is also expected to grow during the forecast period, which will also help in driving the overall Global Erectile Dysfunction Devices Market growth.

North America is expected to dominate the overall Global Erectile Dysfunction Devices Market:

North America is expected to dominate the overall Erectile Dysfunction Devices market during the forecast period. This domination is owing to the growing prevalence of erectile dysfunction cases in the region. As per CDC 2022, ED is common among middle-aged and older men, and almost 30 million in the United States have it.

Most men suffer from erection problems frequently. These problems can occur at any age. But they are more common in older men, who often have other health problems. Other health problems, such as diabetes, high blood pressure, anxiety, depression, and drinking too much alcohol or smoking are major causes of erectile dysfunction among men. Hypertension is additionally another major disorder that causes male erectile dysfunction, and as reported by CDC in 2018, the prevalence of hypertension has grown at a substantial rate, with approximately 65 million people affected by the condition within the United States.

Thus, the burgeoning cases of erectile dysfunction, cardiovascular diseases like hypertension will contribute to the growth of the Erectile Dysfunction Devices Market in the region as the demand is very high.

Further, in North America and at the global level the United States represents the largest market worldwide supported by developed healthcare infrastructure and strong adoption of technologically advanced products owing to the rise in healthcare expenditure by the government. One such technological advancement was in January 2022, Alma Lasers launched Alma Duo, a device for treating Erectile Dysfunction (ED) in men. It uses the shock wave technology-focused low-intensity extracorporeal shock wave therapy (LI-ESWT). Making it available in North America only.

Europe and Asia-Pacific region have the future potential growth for the Global Erectile Dysfunction Devices market. This is owing to the rising burden of smoking, tobacco, and alcohol consumption rates in the European region countries and Asian countries. Rising product launch and commercialization agreements among the key manufacturers and other companies are anticipated to boost the Erectile Dysfunction Devices market. For instance, in September 2020, a european company, Francis Medical announced that it received a $4 million equity investment from erectile dysfunction key player Coloplast. Such initiatives are anticipated to boost the Erectile Dysfunction Devices Market.

Erectile Dysfunction Devices Market Key Players:

Some of the key market players operating in the Global Erectile Dysfunction Devices Market include Coloplast Corporation, Zimmer Aesthetics, Augusta Medical Systems, Medispec Ltd., MTS Medical UG, NOVAmedtek, Shenzhen Huikang Medical Apparatus Co., Ltd., Promedon, Boston Scientific Corporation, Global Life Technologies LLC, Zephyr Surgical Implants, UroMatrix Medical Systems, Pos-T-Vac Medical, Owen Mumford Ltd, Vacurect Manufacturing (PTY) Ltd., The Elator, SILIMED, Tyna International Ltd., STORZ MEDICAL AG, Reflexonic, LLC, and others.

Recent Developmental Activities in the Erectile Dysfunction Devices Market:

In January 2022, manufacturer Giddy launched Eddie, a first-of-its-kind, wearable, FDA Class II erectile dysfunction device, which works with the natural physiology of an erection.

In January 2020, Launch Medical launched The Rocket, the world's first at-home treatment device that utilizes soundwave therapy to completely reverse symptoms of ED. The benefit of the device is that it improves sexual performance without drugs, has no side effects, and has zero downtime.

In July 2019, Boston Scientific Corporation launched the Tactra(TM) Malleable Penile Prosthesis in the United States for the treatment of erectile dysfunction (ED).

Key Takeaways from the Erectile Dysfunction Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Erectile Dysfunction Devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Erectile Dysfunction Devices Market.

Various opportunities are available for the other competitor in the Erectile Dysfunction Devices Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Erectile Dysfunction Devices market growth in the coming future?

Target Audience who can be benefited from this Erectile Dysfunction Devices Market Ket Report Study

Erectile Dysfunction Devices providers

Research organizations and consulting companies

Erectile Dysfunction Devices related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Erectile Dysfunction Devices

Various End-users want to know more about the Erectile Dysfunction Devices Market and the latest technological developments in the Erectile Dysfunction Devices market.

Frequently Asked Questions for Erectile Dysfunction Devices Market:

1. What are Erectile Dysfunction Devices?

Blood pumps through the penis for an erection to take place, allowing it to extend and stiffen, which is sparked by stimuli from the brain to the genital nerves. When these impulses are blocked or the supply of blood to the penis is reduced, Erectile Dysfunction Devices are used to treat the patient and restore normal functioning.

2. What is the market for Global Erectile Dysfunction Devices?

Global Erectile Dysfunction Devices Market was valued at USD 1.77 billion in 2023, growing at a CAGR of 9.46% during the forecast period from 2024 to 2030, to reach USD 3.04 billion by 2030.

3. What are the drivers for Global Erectile Dysfunction Devices?

The major drivers driving the demand for Erectile Dysfunction Devices are the growing cases of erectile dysfunction, increase in the geriatric population of men, cardiovascular diseases and diabetes, sedentary lifestyle that involves smoking, alcohol consumption, obesity, and technological advancements.

4. Who are the key players operating in Global Erectile Dysfunction Devices?

Some of the key market players operating in the Erectile Dysfunction Devices market include Coloplast Corporation, Zimmer Aesthetics, Augusta Medical Systems, Medispec Ltd., MTS Medical UG, NOVAmedtek, Shenzhen Huikang Medical Apparatus Co., Ltd., Promedon, Boston Scientific Corporation, Global Life Technologies LLC, Zephyr Surgical Implants, UroMatrix Medical Systems, Pos-T-Vac Medical, Owen Mumford Ltd, Vacurect Manufacturing (PTY) Ltd., The Elator, SILIMED, Tyna International Ltd., STORZ MEDICAL AG, Reflexonic, LLC, and others.

5. Which regions has the highest share in the Erectile Dysfunction Devices market?

North America is expected to dominate the overall global Erectile Dysfunction Devices market during the forecast period from 2024 to 2030. This domination is due to the growing prevalence of erectile dysfunction cases in the region.

Table of Contents

1. Erectile Dysfunction Devices Market Report Introduction

2. Erectile Dysfunction Devices Market Executive summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment
• 2.4. Financial Benchmarking

3. Regulatory and Patent Analysis

• 3.1. The United States
• 3.2. Europe
  • 3.2.1. Germany
  • 3.2.2. France
  • 3.2.3. Italy
  • 3.2.4. Spain
  • 3.2.5. The U.K.
• 3.3. Japan

4. Erectile Dysfunction Devices Market Key factors analysis

• 4.1. Erectile Dysfunction Devices Market Drivers
  • 4.1.1. The growing cases of erectile dysfunction
  • 4.1.2. Increase in the geriatric population of men
  • 4.1.3. The surge in cardiovascular diseases and sedentary lifestyle
  • 4.1.4. Rising technological advancements
• 4.2. Erectile Dysfunction Devices Restraints and Challenges
  • 4.2.1. High cost of advanced and invasive devices
  • 4.2.2. Presence of alternative drug treatment options
• 4.3. Erectile Dysfunction Devices Opportunities
  • 4.3.1. Growing preference for devices that can be used without causing discomfort
  • 4.3.2. Growing awareness about these advanced devices in developing countries

5. Erectile Dysfunction Devices Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Erectile Dysfunction Devices Market

7. Erectile Dysfunction Devices Market layout

• 7.1. By Product
  • 7.1.1. Penile Implants
  • 7.1.2. Shockwave Therapy Devices
  • 7.1.3. Vacuum Therapy Devices
  • 7.1.4. Others
• 7.2. By Approach
  • 7.2.1. Invasive
  • 7.2.2. Non-Invasive
• 7.3. By End User
  • 7.3.1. Hospitals and Clinics
  • 7.3.2. Ambulatory Surgical Centers (ASCs)
  • 7.3.3. Others
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. North America Erectile Dysfunction Devices Market, by Product
    • 7.4.1.2. North America Erectile Dysfunction Devices Market, by Approach
    • 7.4.1.3. North America Erectile Dysfunction Devices Market, by End User
    • 7.4.1.4. North America Erectile Dysfunction Devices Market, by Country
    • 7.4.1.4.1. United States
    • 7.4.1.4.2. Canada
    • 7.4.1.4.3. Mexico
  • 7.4.2. Europe
    • 7.4.2.1. Europe Erectile Dysfunction Devices Market, by Product
    • 7.4.2.2. Europe Erectile Dysfunction Devices Market, by Approach
    • 7.4.2.3. Europe Erectile Dysfunction Devices Market, by End User
    • 7.4.2.4. Europe Erectile Dysfunction Devices Market, by Country
    • 7.4.2.4.1. France
    • 7.4.2.4.2. Germany
    • 7.4.2.4.3. United Kingdom
    • 7.4.2.4.4. Italy
    • 7.4.2.4.5. Spain
    • 7.4.2.4.6. Russia
    • 7.4.2.4.7. Rest of Europe
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. Asia-Pacific Erectile Dysfunction Devices Market, by Product
    • 7.4.3.2. Asia-Pacific Erectile Dysfunction Devices Market, by Approach
    • 7.4.3.3. Asia-Pacific Erectile Dysfunction Devices Market, by End User
    • 7.4.3.4. Asia-Pacific Erectile Dysfunction Devices Market, by Country
    • 7.4.3.4.1. China
    • 7.4.3.4.2. Japan
    • 7.4.3.4.3. India
    • 7.4.3.4.4. Australia
    • 7.4.3.4.5. South Korea
    • 7.4.3.4.6. Rest of Asia Pacific
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. RoW Erectile Dysfunction Devices Market, by Product
    • 7.4.4.2. RoW Erectile Dysfunction Devices Market, by Approach
    • 7.4.4.3. RoW Erectile Dysfunction Devices Market, by End User
    • 7.4.4.4. RoW Erectile Dysfunction Devices Market, by Region
    • 7.4.4.4.1. Middle East
    • 7.4.4.4.2. Africa
    • 7.4.4.4.3. South America

8. Erectile Dysfunction Devices Global Company Share Analysis - Key 3-5 Companies

9. Erectile Dysfunction Devices Company and Product Profiles

• 9.1. Coloplast Corporation
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4. Product Listing
  • 9.1.5. Entropy
• 9.2. Zimmer Aesthetics
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4. Product Listing
  • 9.2.5. Entropy
• 9.3. Augusta Medical Systems
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4. Product Listing
  • 9.3.5. Entropy
• 9.4. Medispec Ltd.
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4. Product Listing
  • 9.4.5. Entropy
• 9.5. MTS Medical UG
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4. Product Listing
  • 9.5.5. Entropy
• 9.6. NOVAmedtek
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4. Product Listing
  • 9.6.5. Entropy
• 9.7. Shenzhen Huikang Medical Apparatus Co., Ltd.
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4. Product Listing
  • 9.7.5. Entropy
• 9.8. Promedon
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4. Product Listing
  • 9.8.5. Entropy
• 9.9. Boston Scientific Corporation
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4. Product Listing
  • 9.9.5. Entropy
• 9.10. Global Life Technologies LLC
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4. Product Listing
  • 9.10.5. Entropy
• 9.11. Zephyr Surgical Implants
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4. Product Listing
  • 9.11.5. Entropy
• 9.12. UroMatrix Medical Systems
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4. Product Listing
  • 9.12.5. Entropy
• 9.13. Pos-T-Vac Medical
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4. Product Listing
  • 9.13.5. Entropy
• 9.14. Owen Mumford Ltd.
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4. Product Listing
  • 9.14.5. Entropy
• 9.15. Vacurect Manufacturing (PTY) Ltd.
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4. Product Listing
  • 9.15.5. Entropy
• 9.16. The Elator
  • 9.16.1. Company Overview
  • 9.16.2. Company Snapshot
  • 9.16.3. Financial Overview
  • 9.16.4. Product Listing
  • 9.16.5. Entropy
• 9.17. SILIMED
  • 9.17.1. Company Overview
  • 9.17.2. Company Snapshot
  • 9.17.3. Financial Overview
  • 9.17.4. Product Listing
  • 9.17.5. Entropy
• 9.18. Tyna International Ltd.
  • 9.18.1. Company Overview
  • 9.18.2. Company Snapshot
  • 9.18.3. Financial Overview
  • 9.18.4. Product Listing
  • 9.18.5. Entropy
• 9.19. STORZ MEDICAL AG
  • 9.19.1. Company Overview
  • 9.19.2. Company Snapshot
  • 9.19.3. Financial Overview
  • 9.19.4. Product Listing
  • 9.19.5. Entropy
• 9.20. Reflexonic, LLC
  • 9.20.1. Company Overview
  • 9.20.2. Company Snapshot
  • 9.20.3. Financial Overview
  • 9.20.4. Product Listing
  • 9.20.5. Entropy

10. Project Approach

• 10.1. Secondary Sources
• 10.2. Primary Sources
• 10.3. Data Triangulation
• 10.4. Key Expert Opinions

11. KOL Views

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight